Trials of vitamin B12 supplementation in children 6-30 months have shown an increased risk of diarrhea and respiratory infections among participants. These results are not consistent with studies in adults that showed improvement of the immune response following treatment with vitamin B12. We sought to determine how the adequacy of vitamin B12 concentrations in breast milk could act as immune modulator and protect against the incidence of diarrhea and respiratory infections of children up to 18 months in urban Tanzania.
Introduction
Vitamin B12 deficiency is common among women and infants in low and middle-income countries, partially due to inadequate intake and limited diet diversity (1) . Infants who develop vitamin B12 deficiency due to inadequate intake from breast milk or other sources may be at increased risk for infections, growth deficits, and neurodevelopmental delays (2) . A recent clinical trial in India reported that vitamin B12 supplementation among children 6-30 months of age decreased the risk of persistent diarrhea, but there was no effect on the incidence of diarrhea overall or acute lower respiratory tract infections (3) .
Previous studies in adults have reported enhancement of cellular immune response following vitamin B12 supplementation (4) and restoration of both cellular and humoral immune responses following vitamin B12 treatment (5) . As a result, maternal breast milk vitamin B12 levels may be an infant immune modulator and determinant of infectious disease risk for breastfeeding infants.
We tested the hypothesis that greater concentration of vitamin B12 in breast milk is protective against the incidence of childhood diarrhea and respiratory infections in a cohort of mother and infant pairs in Dar es Salaam, Tanzania.
Methods
A random sample of 500 women who participated in a randomized trial of multivitamin supplementation (6) Research Center in Davis, California for analysis by competitive chemiluminescent enzyme immunoassay (7) . Three samples were too small for analysis, four samples were collected more than eight weeks after delivery, and two could not be linked to randomized study participants leaving 491 samples.
Breast milk vitamin B12 concentration below the cut-off value of 310 pmol/L was used to define less than the required adequate intake (AI) (8) .
Child morbidity was assessed once a month from birth to 18 months of age. Acute respiratory infection was defined by the acute symptoms of common cold or a cough, difficulties in breathing and any fever. Diarrhea was defined as more than three loose stools per day as diagnosed by the study clinician.
Log-binomial models were used to determine the relative risk of diarrhea and any acute respiratory infection during follow-up comparing those with or without adequate intake (AI) of vitamin B12 in their breast milk. Generalized estimating equations (GEE) were used to account for repeated measurements of acute respiratory and diarrhea variables in infants. In multivariable models, all dichotomous and continuous covariates with p-value less than 0.20 or categorical covariates with p-value for an individual level compared with a reference level less than 0.20 were used to fit a parsimonious multivariable model. The resulting multivariable models for acute respiratory infection included adjustment for child gender, birth weight, and maternal hemoglobin at 6 weeks postpartum. The multivariable model for diarrhea included adjustment for treatment arm, maternal education, wealth score, baseline BMI, and maternal hemoglobin at 6 weeks. In a post hoc analysis, we also assessed effect modification by child gender with a likelihood ratio test comparing a model containing an interaction term between b12 status and gender to a model without it.
Results
Characteristics of the study population are presented in Table 1 . Out of the 491 women included in the study, 345 (70%) had less than the adequate intake value of vitamin B12 in breast milk (<310 pmol/L). Vitamin B12 concentration in breast milk at the 6 th week postpartum was not associated with the risk of incident respiratory infection or diarrheal disease in infants (Table 2) . However, we observed that child gender appeared to modify the association of vitamin B12 breast milk status on diarrhea (p-value for interaction, P = 0.04). Low breast milk B12 may have a greater magnitude of risk of diarrhea among female infants (RR = 1.20, 95% CI = 0.86-1.67) as compared to males (RR = 0.82, 95% CI = 0.61-1.11) but neither association reached statistical significance.
Discussion
Our study determined a high proportion of women (70%) with less than adequate intake (AI) of vitamin B12 in breast milk in urban Tanzania. It was slightly lower than that reported in a study conducted in Kenya (89%) where breast milk samples were collected at 6 months postpartum and Cambodia (75%) where breast milk was collected at 12 months postpartum and the cut-off value to define adequate intake (AI) was taken to be 365 pmol/L (8, 9) .
In this study, we found no overall association of breast milk vitamin B12 status with incident diarrhea and acute respiratory infections. Our results are similar to results from India by Strand and colleagues that found no association of infant vitamin B12 deficiency with incidence of respiratory tract infection (10) .
Contrary to our results, a cross-sectional study in Nepal reported a high prevalence of vitamin B12 deficiency among children with acute diarrhea enrolled in a zinc supplementation trial (11).
The strength of this study lies in repeated measures of childhood morbidity over the first 18 months.
Conclusion
Overall, the proportion of women with concentrations indicating less than the adequate intake (AI) of vitamin B12 in their breast milk is high in urban Tanzania. We found no association of vitamin B12 concentration in breast milk with incidence of diarrhea and respiratory infections among Tanzanian infants. Prospective studies that measure the longitudinal variation of breast milk B12 concentration and the incidence of childhood infections are needed to clarify its role in childhood infections.
Limitations
Our study had several limitations. First, we assessed vitamin B12 concentration at a single time-point which does not allow for assessment of changes in breast milk composition over time. In addition, we did not have information on the concentrations of other micronutrients in breast milk (12), maternal antibodies, the frequency of breastfeeding and gut microbiota (13) which may also influence the incidence of diarrhea and respiratory infections. Further, no information was available on diarrhea severity, which may modify its relationship to B12 status (14). 
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